FibroBiologics (FBLG) News Today → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free FBLG Stock Alerts $11.35 -0.45 (-3.81%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | globenewswire.comFibroBiologics Announces 2024 Annual Meeting of StockholdersMay 15, 2024 | msn.comFBLG Stock Earnings: FibroBiologics, Inc. – Common Stock Reported Results for Q1 2024May 14, 2024 | globenewswire.comFibroBiologics Files 2024 First Quarter ReportMay 11, 2024 | americanbankingnews.comFibroBiologics (NASDAQ:FBLG) Trading 6.3% Higher May 7, 2024 | globenewswire.comFibroBiologics to Present at the BIO International Convention 2024April 26, 2024 | msn.comFibroBiologics files to sell 1.8M unitsApril 25, 2024 | finance.yahoo.comFibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based SpheroidsApril 15, 2024 | finance.yahoo.comFibroBiologics, Inc. (FBLG)April 15, 2024 | finance.yahoo.comFibroBiologics, Inc. (FBLG) Interactive Stock Chart - Yahoo FinanceApril 12, 2024 | investing.comFibroBiologics secures Australian patent for cartilage repairApril 11, 2024 | finanznachrichten.deFibrobiologics, Inc.: FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent OfficeApril 11, 2024 | globenewswire.comFibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent OfficeApril 6, 2024 | uk.investing.comFibroBiologics reports promising wound healing studyApril 4, 2024 | globenewswire.comFibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USAMarch 28, 2024 | globenewswire.comFibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of LupusMarch 19, 2024 | seekingalpha.comFibroBiologics reports encouraging early data for diabetes cell therapyMarch 19, 2024 | prnewswire.comFibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes TreatmentMarch 13, 2024 | prnewswire.comFibroBiologics to Present at Advanced Wound Care Summit USAMarch 6, 2024 | morningstar.comFibroBiologics Inc FBLGMarch 6, 2024 | prnewswire.comFibroBiologics Appoints Ruben A. Garcia as General CounselMarch 5, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 09:03 AM with a stated reason of "LULD pause."February 29, 2024 | prnewswire.comFibroBiologics Files 2023 Form 10-K Annual ReportFebruary 20, 2024 | prnewswire.comFibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) ForumFebruary 16, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 03:02 PM with a stated reason of "LULD pause."February 15, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 09:02 AM with a stated reason of "LULD pause." Trading set to resume at 09:02 AM. February 13, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 13, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 02:02 PM with a stated reason of "LULD pause."February 8, 2024 | finance.yahoo.comFibroBiologics Announces Three United States Patents for Fibroblast TechnologyFebruary 8, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 09:02 AM with a stated reason of "LULD pause."February 7, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 7, 2024 | msn.comFibroBiologics Broadens IP Reach with Japanese PatentsFebruary 1, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 11:02 AM with a stated reason of "LULD pause."February 1, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 10:02 AM with a stated reason of "LULD pause." Trading set to resume at 10:02 AM. February 1, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 09:02 AM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 03:01 PM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 03:01 PM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 03:01 PM with a stated reason of "LULD pause." Trading set to resume at 03:01 PM. January 31, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 03:01 PM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 02:01 PM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 02:01 PM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 02:01 PM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 02:01 PM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "FBLG" at 01:01 PM with a stated reason of "LULD pause." Get FibroBiologics News Delivered to You Automatically Sign up to receive the latest news and ratings for FBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… FBLG Media Mentions By Week FBLG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FBLG News Sentiment▼0.340.42▲Average Medical News Sentiment FBLG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FBLG Articles This Week▼42▲FBLG Articles Average Week Get FibroBiologics News Delivered to You Automatically Sign up to receive the latest news and ratings for FBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AMRN News Today RVNC News Today ORGO News Today ANRO News Today ACIU News Today TERN News Today NBTX News Today PGEN News Today KRRO News Today VRCA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FBLG) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.